Bio-Medicine: Pfizer shows support for open access ( Pfizer today announced details of a ...)

"Pfizer today announced details of a membership agreement with BioMed Central to cover publication costs for research articles published by its researchers. Pfizer's BioMed Central membership arrangement means that Pfizer will centrally cover the publication fees for any researcher employed or funded by Pfizer when they submit a research article to one of BioMed Central's 190+ peer-reviewed open access journals. By funding open access publication fees in this way, Pfizer aims to make it as straightforward as possible for its researchers to make their research results universally accessible."